|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 03751032.8 (espacenet) (Federated) (European Patent Register), 20031006 | | Patent/reg. no. and date | DK/EP 1551409, 20070321 | | Publication date | 20050713 | | Priority no. and date | GB 0223380, 20021009 | | EP pub. no. and date |
EP 1551409 20050713 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | BARGE, Alan,
AstraZeneca R & D Alderley, Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 31/7068 (2006.01) , A61P 35/00 (2006.01) | | Title | Anvendelse af quinazolinderivatet ZD6474 kombineret med gemcitabin og eventuelt ioniserende stråling ved behandling af cancer | | Int. application no. | GB2003004334 | | Int. publication no. | WO2004032937 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
